HLA-DR

From Wikipedia, the free encyclopedia

ligand (Staphylococcal enterotoxin 1-C peptide:pkyvkqntlklat) within the binding pocket of DR αβ101
DR1 binding pocket with ligand PDB 2G9H [1]
major histocompatibility complex, class II, DR
Structure
Type Cell surface receptor
Subunit αβ-heterodimer
MMDB 40432
Identifiers
alpha
Symbol(s) HLA-DRA, HLA-DRA1
Entrez 3122
OMIM 142860
Identifiers
beta 1
beta 3
Symbol(s) HLA-DRB1 HLA-DRB3
Entrez 3123 3125
OMIM 142857
Identifiers
beta 4
beta 5
Symbol(s) HLA-DRB4 HLA-DRB5
Entrez 3126 3127
OMIM 604776
Shared data
Locus chr.6 6p21.31

HLA-DR is a major histocompatibility complex, class II, cell surface receptor encoded by the human leukocyte antigen complex on chromosome 6 region 6p21.31. Receptor is frequently found with ligand, a peptide of 9 amino acids in length or longer, within the binding groove. The receptor/peptide complex is a ligand for T-cell receptor (TCR). HLA, human leukocyte antigens, were originally defined as cell surface antigens that mediate graft-versus-host disease, which resulted in the rejection of tissue transplants in HLA mismatched donors. Identification of these antigens has lead to greater success and longevity in organ transplant.

HLA-DR is also involved in several autoimmune conditions, disease susceptibility and disease resistance. It is also closely linked to HLA-DQ and this linkage often makes it difficult to resolve the more causative factor in disease.

Molecules particularly HLA-DR are upregulated in response to signalling. In the instance of an infection the peptide (such as the staphlococcal enterotoxin I peptide show in the two illustrations) is bound into a DR molecule and presented to a few of a great many T-cell receptors found on T-helper cells. These cells then bind to antigens on the surface of B-cells stimulating B-cell proliferation.

Contents

[edit] Function

Illustration of DR receptor presenting antigen to TCR on T-helper cell
Illustration of DR receptor presenting antigen to TCR on T-helper cell

The primary function of HLA-DR is to present peptide antigens, potentially foreign in origin, to the immune system for the purpose of eliciting or suppressing T-(helper)-cell responses that eventually lead to the production of antibodies against the same peptide antigen. Antigen presenting cells (macropahges, B-cells and dendritic cells) are the cells in which DR are typically found. Increased abundance of DR 'antigen' on the cell surface is often in response to stimulation, and, therefore, DR is also a marker for immune stimulation.

[edit] Structure

HLA-DR is a αβ heterodimer, cell surface receptor, each subunit contains 2 extracellular domains, a membrane spanning domain and a cytoplasmic tail. Both α and β chains are anchored in the membrane. The N-terminal domain of the mature protein forms an alpha-helix that forms the exposed part of the binding groove, the C-terminal cytoplasmic region interact with the other chain forming a beta-sheet under the binding groove spanning to the cell membrane. The majority of the peptide contact positions are in the 1st 80 residues of each chain.

[edit] Genetics

The genetics of HLA-DR is complex. HLA-DR is encoded by several loci

  • α-chain
    • DRA (DRA1) locus
      • functional variation in mature DRA gene products is absent
      • (see table) reduces the potential functional combinations from ~1400 to ~400 (table is not exact because new alleles are continually being added not all new alleles are functional variants of the mature subunits.
28 (of 75) Most common DR-DQ haplotypes in Caucasian Americans
DR DR-DQ DR DQ Freq
Serotype haplotype B1 A1 B1 %[2] rank
DR1 DR1-DQ5 0101 0101 0501 9. 1 4
0102 0101 0501 1. 4 15
0103 0101 0501 0. 5 25
DR3 DR3-DQ2 0301 0501 0201 13. 1 2
DR4 DR4-DQ7 0401 0300 0301 5. 4 7
0407 0300 0301 0. 9 19
DR4-DQ8 0401 0300 0302 5. 0 8
0402 0300 0302 1. 0 17
0403 0300 0302 0. 4 26
0404 0300 0302 3. 9 9
0405 0300 0302 0. 3 28
DR7 DR7-DQ2 0701 0201 0202 11. 1 3
DR7-DQ9 0701 0201 0303 3. 7 10
DR8 DR8-DQ4 0801 0401 0402 2. 2 13
DR8-DQ7 0803 0601 0301 0. 1 rare
DR9 DR9-DQ9 0901 0300 0303 0. 8 20
DR10 DR10-DQ5 1001 0104 0501 0. 7 22
DR11 DR11-DQ7 1101 0505 0301 5. 6 5
1103 0505 0301 0. 3 27
1104 0505 0301 2. 7 12
DR12 DR12-DQ7 1201 0505 0301 1. 1 10
DR13 DR13-DQ6 1301 0103 0603 5. 6 6
1302 0102 0604 3. 4 11
1302 0102 0609 0. 7 22
DR13-DQ7 1303 0505 0301 0. 7 21
DR14 DR14-DQ5 1401 0104 0503 2. 0 14
DR15 DR15-DQ6 1501 0102 0602 14. 2 1
1502 0103 0602 0. 7 24
DR16 DR16-DQ5 1601 0102 0502 1. 0 18
  • β-chain [3]
    • DRB1 locus (ubiquitous)
      • very large number of functionally variable gene products.
    • DRB3 locus (variable-associated with certain DR types)
      • modest number of functionally variable gene products.
    • DRB4 locus (variable-associated with certain DR types)
      • modest number of functionally variable gene products.
    • DRB5 locus (variable-associated with certain DR types)
      • modest number of functionally variable gene products.
  • linkage (See Table)
    • DQA1 and DQB1
      • Linkage disequilibrium exists for many DR-DQ types.
    • Nomenclature issues. Some older studies may refer to DR15 or 16 as DR2 and DQ5 and DQ6 as DQ1 therefore a haplotype DR2-DQ1 is ussually referring to DR15-DQ6 but could be referring to DR16-DQ5. DR5 is used to refer to DR11 and DR12, in which case DQ3 might be used. In these instances DQ3 almost always can be interpreted as DQ7, but DR5 is most often DR11 and less frequently DR12. Similar issues exist for DR6 versus DR13 and DR14. DR6-DQ1 can refer

to either DR13-DQ6 or less frequently DR14-DQ5, but DR6-DQ3 or DR6-DQ7 generally refers to DR13-DQ7. Even older literature has more confusing designations. By looking at the change of disease association with improved testing we can see how science has evolved over time.

[edit] Evolution and Allele Frequencies

There is a relatively extreme level of allelic diversity at HLA DRB1, it is second only to HLA-B locus in number of allelic variants, these two probably top coding sequence variation rate within human genome. This means HLA-DRB1 is rapidly evolving, much more rapidly than almost all other genomic loci. Much of the variation at HLA DRB1 occurs at peptide contact positions in the binding groove, as a result many of the alleles alter the way the DR binds peptide ligands and changes the repertoire each receptor can bind. This means that most of the changes are functional in nature, and therefore are under selection. In the HLA region, genes are under heterozygous or balancing selection, although certain alleles appear to be under positive or negative selection, either in the past or present
HLA generally evolve through a process of gene conversion a form of short distance or 'abortive' recombination. Functional motifs in other HLA are transferred to form new alleles, and frequently new DR isoforms. HLA-DR represents an extreme example of this. A survey of X-linked chromosome reveals that most human loci have undergone fixation within the last 600,000 years, and diploid loci have undergone significant proportion of fixation in that period of time. The level of deep branching at X-linked loci indicates loci were close to fixation or fixed at the end of the human population bottleneck ~150 kya. The HLA-DR locus represents a major exception to this observation[4]. Based on distribution of mjor groupings in the Human population it is possible to assert that more than a dozen major variants survived the constriction. This observation is supported by the concept of a heterozygous selection coefficient operating on the HLA-DR, and at the HLA-DRB1 locus to a greater degree relative to HLA-DQB1 and HLA-DPB1. Most of the HLA alleles currently present in the human population can be explained by gene conversion between these ancient ancestral types[5], some that persist into the extant population.

[edit] Disease associations

Because DR alleles are in disequilibrium with HLA-DQ loci, early studies often cannot resolve exact disease association. In such cases the DR-DQ haplotype will be referred to. See table above on DR-DQ linkage in caucasians. (*#### = DRB1*####)

[edit] DR1

Diseases associated with DR1 serotypes or cognate alleles are: seronegative[6]-rheumatoid arthritis[7][8], penicillamine-induced myasthenia[9], and schizophrenia[10]


[edit] DR2

DR2 is a broad antigen serotype made up of split antigens DR15 and DR16 serotypes. Diseases associated with DR2 serotypes or cognate alleles are: Goodpasture syndrome, multiple sclerosis[19], and narcolepsy, tuberculoid leprosy[20], Hashimoto's thyroiditis[21], ulcerative colitis(Japanese)[22], biliary cirrhosis and autoimmune hepatitis[23]

[edit] DR15

Goodpasture syndrome[24], early age onset multiple schlerosis[25], pernicious anaemia[26]

  • 15:DQA1*0102:DQB1*0602 haplotype: cervical cancer (human papillomavirus infection)[27]
  • *1501: Goodpasture syndrome[28][29], juvenile rheumatoid arthritis [30], allergic bronchopulmonary aspergillosis[31], multiple schlerosis[32], systemic lupus erythematosus[33], cervical cancer (human papillomavirus infection)[34], and Sjogren's syndrome associated with systemic lupus erythematosus[35]
    • *1501:DQA1*0102:DQB1*0602 haplotype: cervical cancer (human papillomavirus infection)[34]
  • *1502: Systemic lupus erythematosus[36], systemic sclerosis (SSc) & anti-DNA topoisomerase I (anti-topo I) antibody[37]
    • *1502:DQA1*????:DQB1*0501 haplotype: Systemic lupus erythematosus[36]
  • *1503: Trypannosome cruzi infection with cardiomyopathy[38], allergic bronchopulmonary aspergillosis[39], multiple sclerosis[32], cervical cancer (human papillomavirus infection)[27]

[edit] DR16

Chaga's cardiomyopathy[40], rheumatic heart disease[41], coronary artery ectasia[42], and

  • *1601: Tubeculousis risk[43]
    • *1601:DQA1*0102:DQB1*0502 haplotype: Tubeculousis risk [43]
  • *1602: Juvenile rheumatoid arthritis[30], rheumatic heart disease[41], Takayasu arteritis[44], systemic sclerosis (SSc) & anti-DNA topoisomerase I (anti-topo I) antibody [37][45], melioidosis (Burkholderia pseudomallei infection)[46]
    • *1602:DQA1*0102:DQB1*0502 haplotype: graves disease[47][48], cervical caner (human papilloma virus infection)[49], schleroderma[50]
    • *1602:DQA1*05:DQB1*0301 haplotype: rheumatic heart disease[41], systemic schlerosis[51]


[edit] DR3

DR3 is composed to the DR17 and DR18 split 'antigens' serotypes. Diseases associated with DR2 serotypes or cognate alleles are: early-age onset myasthenia gravis, and opportunistic infections in AIDS[citation needed]. DRB1 alleles covered by DR17 and DR18 include rare *0305, *0306 alleles

[edit] DR17

non-chronic sarcoidosis[52][53], infantile spasm/epilepsy[54], rabies vaccine-induced autoimmune encephalomyelitis[55] and cardiovascular hypertrophy in subjects with arterial hypertension[56]

[edit] DR18

rheumatoid polyarthritis[72]


[edit] DR4

DR4 serotype is a diverse subgroup of antigens composed of several alleles. Diseases associated with DR4 serotype or cognate alleles are: extraarticular[73]rheumatoid arthritis[74], hydralazine-induced female systemic lupus erythematosus[75],pemphigoid gestationis[76], phemphigus foliaceus[77], hypertrophic obstructive cardiomyopathy[78], IgA nephropathy[79]

  • *0401: multiple sclerosis[80], rheumatoid arthritis[81], type 1 diabetes[82][83], lyme disease induced arthritis[84]
  • *0402: drug-triggered[85]/idiopathic pemphigus vulgaris[86], type 1 diabetes[87], SLE associated anti-cardiolipin and anti-beta2GPI[88]
  • *0403: polycystic ovary syndrome[89], SLE associated anti-cardiolipin and anti-beta2GPI[90]
  • *0404: anti-citrullinated fibrinogen[91] in rheumatoid arthritis[92], autoimmune hepatitis[93]
  • *0405: rheumatoid arthritis[94], Autoimmune hepatitis[95], type 1 diabetes[96][97]
    • as part of :DQA1*0303-DQB1*0401 haplotype: type III autoimmune polyglandular syndrome[98], autoimmune hepatitis [99], autoimmune pancreatitis[100]
    • as part of :DQA1*03-DQB1*0302 haplotype: Type 1 diabetes[101][102]
  • *0406: caspase-8 autoantibodies silicosis-systemic sclerosis (SSc)-systemic lupus erythematosus (SLE)[103]
  • DR4-DQ8 juvenile diabetes,coeliac disease, rheumatoid arthritis[104]
  • *0409: T. cruzi infection with cardiomyopathy[38]



[edit] DR5

- persistent generalized lymphadenopathy (PGL)[105] and Kaposi sarcoma in AIDS[106], juvenile rheumatoid arthritis[107][108], goitrous autoimmune thyroiditis[109][110], mycosis fungoides[111], polyglandular deficiency syndrome[112], systemic sclerosis[113][114], childhood epilepsy[115], early-onset alopecia areata[116], short-ragweed Ra6 allergy[117], primary antiphospholipid syndrome[118], and increased longevity in the Dutch[119]

[edit] DR11

Diseases associated with DR11 serotype or cognate alleles are: Grape anaphylaxis[120], well-differentiated thyroid cancer[121], low antibody production in Hepatitis C[122]*

  • *11: systemic sclerosis (SSc) & anti-DNA topoisomerase I (anti-topo I) antibody [37]
  • *11:DQA1*0505:DQBA1*0301 haplotype: Trans-haplotype isoform celiac disease[123]
  • *1101: Anti-Ro/SSA with anti-La/SSB antibodies in neonatal lupus erythematosus [124], mite sensitive asthma[125], cervical cancer risk (HPV?)[126]
    • *1101:DQA1*0505:DQB1*0301 haplotype: Anti-Ro/SSA with anti-La/SSB antibodies in neonatal lupus erythematosus[124], mite sensitive asthma[125]
  • *1102: Tiopronin intolerance in rheumatoid arthritis[127]
    • *1102:DQA1*0505:DQB1*0301 haplotype: hepatitis B virus persistence[128]
  • *1104: pauciarticular juvenil rheumatoid arthritisJuvenile rheumatoid arthritis[30]

[edit] DR12

Vulval lichen schlerosis [129]

  • *12
    • *12:DQA1*0505:DQBA1*0301 haplotype: Trans-haplotype isoform celiac disease[123], primary antiphospholipid syndrome[130], Tiopronin intolerance in rheumatoid arthritis[127], adult chronic articular Still's disease[131]
    • *1201:DRB3*01/03: colorectal cancer[132]


[edit] DR6

DR6 is a broad-antigen serotype that is further split into DR13 and DR14 antigen serotypes.

[edit] DR13

  • *1302: Early childhood myastenia gravis[133]
    • *1032:DQA1*0102:DQB1*0604: Early childhood myastenia gravis[133]

[edit] DR14

  • *14
    • *14:DQ5 haplotype: increased risk for non-AChR autoantibodies in myasthenia gravis.
  • *1402: juvenile rheumatoid arthritis[30], increased longevity in Okinawans.


[edit] DR7

psoriasis vulgaris

  • *07: T. cruzi infection with cardiomyopathy[38]

[edit] DR8

papillary thyroid carcinomas [134], early onset pauciarticular juvenile chronic arthritis[135][136], primary biliary cirrhosis[137]

  • *0801: primary biliary cirrhosis[138]
  • *0803: primary biliary cirrhosis[138]

[edit] DR9

  • *0901: Early childhood myastenia gravis[133]
    • *0901:DQA1*0301:DQB1*0303 haplotype: Early childhood myastenia gravis[133]

[edit] DR10

DR10 sertoype or cognate alleles are associated with: Lichen planus[139]

  • *1001: Ovarian cancer[140] and invasive squamous cell cervical cancer (SCC)[141]
    • *1001:DQA1*01:DQB1*05 haplotype: Rheumatoid arthritis[142]

[edit] DR51

The following HLA-DRB5 alleles are associated with disease:

  • *0101:
    • *0101:DRB1*1501 Multiple schlerosis[143], leprosy[144]

[edit] DR52

The following DRB3* alleles show association with disease:

  • *0101: Grave's Disease[145][146], pulmonary sarcoidosis[147]
    • *0101:DRB1*0301 : Lofgren's syndrome[148]
  • *0202: Grave's disease[146], serum IgG antibodies to Chlamydia pneumoniae with essential hypertension,[149], acute necrotizing encephalopathy[150]
  • *0301: weak association with anti-cardiolipin antibodies in SLE[151]
    • *0301:DRB1*1302: Crohn's diseaes[152]

[edit] DR53

The HLA-DRB4 alleles are associated with the following diseases:

  • *0101: Hashimoto's thyroiditis[153], vitiligo[154], primary biliary cirrhosis[155], clozapine-induced agranulocytosis[156], Vogt-Koyanagi-Harada [157]

[edit] Nomenclature

Number of Variant Alleles HLA-DR Loci
HLA-DR
HLA -A1 -B1 -B3 to -B51 Potential
Locus # # # Combinations
Alleles[3][158] 3 463 74 1635
Unique Polypeptide 2 394 57 902
Contact Variant 1 ~300 ~30 ~330
1DRB3, DRB4, DRB5 have variable presence in humans

Since DRA gene product is functionally invariable is not necessary to define in the nomenclature DR1 to DR18 serogroups and cognate allele groups. For details about serotypable alleles in each group see Marsh et al[3]. The values in the database change monthly however most of the new entries are very rare alleles. This information is current as of October 2006[158]

[edit] DRB1 Locus

DRB1*01 allele group

  • 21 Alleles: 16 proteins, 0 Nulls
  • DR1 Serotype: *0101, *0102, *0105, *0107, *0108, *0111, *0113, *0114
  • DR1/DR103: *0103
  • Serotype unknown: *0104, *0106, *0109, *0110, *0112, *0115, *0116


DRB1*03 allele group

  • 36 Alleles: 31 proteins
  • DR3(Only) Serotype: *0304, *0307
  • DR17(DR3) Serotype: *0301, (*0303), (*0304)
  • DR18(DR3) Serotype: *0302, *0303
  • Serotype unknown: *0305, *0306, *0308 to *0331


DRB1*04 allele group

  • 68 Alleles: 60 proteins
  • DR4 Serotype: *0401 to *0416
  • Serotype unknown: *0417 to *460


DRB1*07 allele group

  • 12 Alleles: 9 proteins, 1 null
  • DR7 Serotype: *0701, *0704
  • Serotype unknown: *0703, *0705 to *0709, *0711
  • Null: *0710N


DRB1*08 allele group

  • 39 Alleles: 32 proteins
  • DR8 Serotype: *0801 to *0807, and *0810 to *0812
  • Serotype unknown: *0808, *0809, *0813 to *0832


DRB1*09 allele group

  • 7 Alleles: 6 proteins
  • DR9 Serotype: *0901
  • Serotype unknown: *0902 to *0906


DRB1*10 allele group

  • 2 Alleles: 1 proteins
  • DR10 Serotype: *1001


DRB1*11 allele group

  • 73 Alleles: 57 proteins
  • DR11 (weak DR5) Serotype: *1101 to *1105, *1107 to *1110
  • DR5 (weak DR11) Serotype: *1106
  • Serotype unknown: *1111 to *1157


DRB1*12 allele group

  • 17 Alleles: 15 proteins
  • DR12 (weak or no DR5) Serotype: *1201 to *1203, *1206
  • Serotype unknown: *1204, *1205, *1207 to *1215


DRB1*13 allele group

  • 81 Alleles: 74 proteins
  • DR13 (weak or no DR6) Serotype: *1301, *1302, *1304, *1306, *1307, *1310, *1312 to *1314
  • DR6 (weak DR13) Serotype: *1308
  • DR13&Other serotypes: *1303, *1305, *1311,
  • Serotype unknown: *1309, *1315 to *1374


DRB1*14 allele group

  • 68 Alleles: 62 proteins
  • DR14 (weak or no DR6) Serotype: *1401, *1403 to *1405, *1407, *1410 to *1411, *1413 to *1414
  • DR6 (weak DR14) Serotype:
  • DR14&Other serotypes: *1402, *1406, *1408, *1415, *1418
  • Serotype unknown: *1409, *1419 to *1462
  • [Neural Network analysis assigned *1412, *1416, *1417 to broad group DR6, *1415 to DR8]


DRB1*15 allele group

  • 29 Alleles: 21 proteins, 1 Null
  • DR15 (weak or no DR2) Serotype: *1501 to *1505, *1507
  • Serotype unknown: *1506, *1508 to *1516, *1518 to *1522
  • Null: *1517N


DRB1*16 allele group

  • 13 Alleles: 10 proteins
  • DR16 (weak or no DR2) Serotype: *1601, *1602, *1604
  • DR2 (weak DR16) Serotype:
  • DR16&Other serotypes:
  • Serotype unknown: *1603, *1605, *1607 to *1611


[edit] DRB3 Locus

DRB3*01 allele group

  • 15 Alleles: 11 proteins
  • DR52 Serotype: *0101, *0102
  • Serotype unknown: *0103 to *0111

DRB3*02 allele group

  • 25 Alleles: 21 proteins
  • DR52 Serotype: *0201 to *0203
  • Serotype unknown: *0204 to *0221

DRB3*03 allele group

  • 4 Alleles: 3 proteins
  • DR52 Serotype: *0301,
  • Serotype unknown: *0302 to *0303


[edit] DRB4 Locus

  • 13 Alleles: 7 proteins, 4 Nulls
  • DR53 Serotype: *0101, *0103
  • Serotype unknown: *0102, *0104 to *0107
  • Nulls: *0101102N, *01030102N, *0201N, *0301N


[edit] DRB5 Locus

DRB5*01 allele group

  • 14 Alleles: 11 proteins, 2 Nulls
  • DR51 Serotype: *0101, *0102
  • Serotype unknown: *0103 to *0107, *0109, *0110 to *0113
  • Nulls: *0108N, *0110N

DRB5*02 allele group

  • 4 Alleles: 4 proteins
  • DR51 Serotype: *0202,
  • Serotype unknown: *0203 to *0205

[edit] DRB Linkage

DRB1 is linked with other DRB loci in 4 ways

No linkage.

  • DRB1*allele groups
    • *01
    • *08
    • *10

Linkage with DRB3.

  • DR3
    • *03
  • DR5
    • *11
    • *12
  • DR6
    • *13
    • *14

Linkage with DRB4

  • DRB1 allele groups.
    • *07
    • *09

Linked with DRB5 DRB1 allele groups.

  • DR2
    • *15
    • *16

[edit] External links

  • MeSH HLA-DR+antigens
  • Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, Wendon J. (2006). "Reduced monocyte HLA-DR expression: A novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.". Hepatology 44 (1): 34-43. PMID 16799971.
  • Lekkou A, Karakantza M, Mouzaki A, Kalfarentzos F, Gogos C (2004). "Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections.". Clin Diagn Lab Immunol 11 (1): 161-7. PMID 14715564.

[edit] References

  1. ^
  2. ^ Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM, and Fernandez-Vina M (2003). "New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans.". Tissue Antigens 62 (4): 296-307. PMID 12974796.
  3. ^ a b c Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, and Trowsdale J. (2005). "Nomenclature for factors of the HLA System, 2004.". Tissue antigens 65: 301-369. PMID 15787720.
  4. ^ Ayala F (1995). "The myth of Eve: molecular biology and human origins.". Science 270 (5244): 1930-6. PMID 8533083.
  5. ^ Parham P, Ohta T (1996). "Population biology of antigen presentation by MHC class I molecules.". Science 272 (5258): 67-74. PMID 8600539.
  6. ^ Bardin T, Legrand L, Naveau B, Marcelli-Barge A, Debeyre N, Lathrop G, Poirier J, Schmid M, Ryckewaert A, Dryll A (1985). "HLA antigens and seronegative rheumatoid arthritis.". Ann Rheum Dis 44 (1): 50-3. PMID 3855618.
  7. ^ Schiff B, Mizrachi Y, Orgad S, Yaron M, Gazit E (1982). "Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis.". Ann Rheum Dis 41 (4): 403-4. PMID 6981387.
  8. ^ (1986) "HLA-DR antigens in rheumatoid arthritis. A Swiss collaborative study; final report. Swiss Federal Commission for the Rheumatic Diseases, Subcommission for Research.". Rheumatol Int 6 (2): 89-92. PMID 3489975.
  9. ^ Delamere J, Jobson S, Mackintosh L, Wells L, Walton K (1983). "Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.". Ann Rheum Dis 42 (5): 500-4. PMID 6605118.
  10. ^ Narita K, Sasaki T, Akaho R, Okazaki Y, Kusumi I, Kato T, Hashimoto O, Fukuda R, Koyama T, Matsuo K, Okabe Y, Nanko S, Hohjoh H, Tokunaga K (2000). "Human leukocyte antigen and season of birth in Japanese patients with schizophrenia.". Am J Psychiatry 157 (7): 1173-5. PMID 10873932.
  11. ^ del Mar Sáez-de-Ocariz M, Vega-Memije M, Zúñiga J, Salgado N, Ruíz J, Balbuena A, Domínguez-Soto L, Granados J (2005). "HLA-DRB1*0101 is associated with foliaceous pemphigus in Mexicans.". Int J Dermatol 44 (4): 350. PMID 15811100.
  12. ^ Sabouri A, Saito M, Usuku K, Bajestan S, Mahmoudi M, Forughipour M, Sabouri Z, Abbaspour Z, Goharjoo M, Khayami E, Hasani A, Izumo S, Arimura K, Farid R, Osame M (2005). "Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals.". J Gen Virol 86 (Pt 3): 773-81. PMID 15722539.
  13. ^ a b Cardoso C, Uthida-Tanaka A, Magalhães R, Magna L, Kraemer M. "Association between psoriasis vulgaris and MHC-DRB, -DQB genes as a contribution to disease diagnosis.". Eur J Dermatol 15 (3): 159-63. PMID 15908298.
  14. ^ Bonagura V, Vambutas A, DeVoti J, Rosenthal D, Steinberg B, Abramson A, Shikowitz M, Gjertson D, Reed E (2004). "HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis.". Hum Immunol 65 (8): 773-82. PMID 15336778.
  15. ^ a b >Levinson R, Park M, Rikkers S, Reed E, Smith J, Martin T, Rosenbaum J, Foster C, Sherman M, Holland G (2003). "Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome.". Invest Ophthalmol Vis Sci 44 (2): 653-7. PMID 12556395.
  16. ^ Fernandez L, Mendoza J, Martinez A, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Peña A, Diaz-Rubio M, de la Concha E (2004). "IBD1 and IBD3 determine location of Crohn's disease in the Spanish population.". Inflamm Bowel Dis 10 (6): 715-22. PMID 15626888.
  17. ^ Puzanowska B, Prokopowicz D, Ziarko S, Radziwon P, Lapinski T. "The incidence of HLA DRB1*0103 in ulcerative colitis patients in north-eastern Poland.". Hepatogastroenterology 50 (53): 1436-8. PMID 14571756.
  18. ^ Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell D (1997). "Genetic markers may predict disease behavior in patients with ulcerative colitis.". Gastroenterology 112 (6): 1845-53. PMID 9178675.
  19. ^ Stewart G, McLeod J, Basten A, Bashir H (1981). "HLA family studies and multiple sclerosis: A common gene, dominantly expressed.". Hum Immunol 3 (1): 13-29. PMID 7275697.
  20. ^ van Eden W, de Vries R, Mehra N, Vaidya M, D'Amaro J, van Rood J (1980). "HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker.". J Infect Dis 141 (6): 693-701. PMID 6156220.
  21. ^ Azuma Y, Sakurami T, Ueno Y, Ohishi M, Saji H, Terasaki P, Park M (1982). "HLA-DR antigens in Japanese with Hashimoto's thyroiditis and Graves' disease.". Endocrinol Jpn 29 (4): 423-7. PMID 6961032.
  22. ^ Asakura H, Tsuchiya M, Aiso S, Watanabe M, Kobayashi K, Hibi T, Ando K, Takata H, Sekiguchi S (1982). "Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis.". Gastroenterology 82 (3): 413-8. PMID 6947923.
  23. ^ Miyamori H, Kato Y, Kobayashi K, Hattori N (1983). "HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis.". Digestion 26 (4): 213-7. PMID 6409699.
  24. ^ Phelps R, Jones V, Turner A, Rees A (2000). "Properties of HLA class II molecules divergently associated with Goodpasture's disease.". Int Immunol 12 (8): 1135-43. PMID 10917888.
  25. ^ Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J (2000). "HLA-DR15 is associated with lower age at onset in multiple sclerosis.". Ann Neurol 48 (2): 211-9. PMID 10939572.
  26. ^ Ungar B, Mathews J, Tait B, Cowling D (1981). "HLA-DR patterns in pernicious anaemia.". Br Med J (Clin Res Ed) 282 (6266): 768-70. PMID 6783164.
  27. ^ a b Maciag P, Schlecht N, Souza P, Franco E, Villa L, Petzl-Erler M (2000). "Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.". Cancer Epidemiol Biomarkers Prev 9 (11): 1183-91. PMID 11097225.
  28. ^ Robertson J, Wu J, Arends J, Glass W, Southwood S, Sette A, Lou Y (2005). "Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis.". Kidney Int 68 (3): 1061-70. PMID 16105036.
  29. ^ Phelps R, Rees A (1999). "The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity.". Kidney Int 56 (5): 1638-53. PMID 10571772.
  30. ^ a b c d Garavito G, Yunis E, Egea E, Ramirez L, Malagón C, Iglesias A, De La Cruz O, Uribe O, Navarro E, Martinez P, Jaraquemada D (2004). "HLA-DRB1 alleles and HLA-DRB1 shared epitopes are markers for juvenile rheumatoid arthritis subgroups in Colombian mestizos.". Hum Immunol 65 (4): 359-65. PMID 15120191.
  31. ^ Slavin R, Hutcheson P, Chauhan B, Bellone C. "An overview of allergic bronchopulmonary aspergillosis with some new insights.". Allergy Asthma Proc 25 (6): 395-9. PMID 15709450.
  32. ^ a b Quelvennec E, Bera O, Cabre P, Alizadeh M, Smadja D, Jugde F, Edan G, Semana G (2003). "Genetic and functional studies in multiple sclerosis patients from Martinique attest for a specific and direct role of the HLA-DR locus in the syndrome.". Tissue Antigens 61 (2): 166-71. PMID 12694585.
  33. ^ Takeuchi F, Nakano K, Nabeta H, Hong G, Kawasugi K, Mori M, Okudaira H, Kuwata S, Tanimoto K (2005). "Genetic contribution of the tumour necrosis factor (TNF) B + 252*2/2 genotype, but not the TNFa,b microsatellite alleles, to systemic lupus erythematosus in Japanese patients.". Int J Immunogenet 32 (3): 173-8. PMID 15932622.
  34. ^ a b Apple R, Erlich H, Klitz W, Manos M, Becker T, Wheeler C (1994). "HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.". Nat Genet 6 (2): 157-62. PMID 8162070.
  35. ^ Manoussakis M, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli F, Moutsopoulos H (2004). "Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.". Arthritis Rheum 50 (3): 882-91. PMID 15022331.
  36. ^ a b Sirikong M, Tsuchiya N, Chandanayingyong D, Bejrachandra S, Suthipinittharm P, Luangtrakool K, Srinak D, Thongpradit R, Siriboonrit U, Tokunaga K (2002). "Association of HLA-DRB1*1502-DQB1*0501 haplotype with susceptibility to systemic lupus erythematosus in Thais.". Tissue Antigens 59 (2): 113-7. PMID 12028537.
  37. ^ a b c Kuwana M, Kaburaki J, Arnett F, Howard R, Medsger T, Wright T (1999). "Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.". Arthritis Rheum 42 (3): 465-74. PMID 10088769.
  38. ^ a b c García Borrás S, Diez C, Cotorruelo C, Pellizon O, Biondi C, Beloscar J, Bottasso O, Racca A (2006). "HLA class II DRB1 polymorphism in Argentinians undergoing chronic Trypanosoma cruzi infection.". Ann Clin Biochem 43 (Pt 3): 214-6. PMID 16704757.
  39. ^ Slavin R, Hutcheson P, Chauhan B, Bellone C. "An overview of allergic bronchopulmonary aspergillosis with some new insights.". Allergy Asthma Proc 25 (6): 395-9. PMID 15709450.
  40. ^ Cruz-Robles D, Reyes P, Monteón-Padilla V, Ortiz-Muñiz A, Vargas-Alarcón G (2004). "MHC class I and class II genes in Mexican patients with Chagas disease.". Hum Immunol 65 (1): 60-5. PMID 14700597.
  41. ^ a b c Hernández-Pacheco G, Aguilar-García J, Flores-Domínguez C, Rodríguez-Pérez J, Pérez-Hernández N, Alvarez-Leon E, Reyes P, Vargas-Alarcón G (2003). "MHC class II alleles in Mexican patients with rheumatic heart disease.". Int J Cardiol 92 (1): 49-54. PMID 14602216.
  42. ^ Akdemir R, Ozhan H, Gunduz H, Erbilen E, Yazici M, Duran S, Orkunoglu F, Albayrak S, Imirzalioglu N, Uyan C (2004). "HLA-DR B1 and DQ B1 polymorphisms in patients with coronary artery ectasia.". Acta Cardiol 59 (5): 499-502. PMID 15529553.
  43. ^ a b Dubaniewicz A, Moszkowska G, Szczerkowska Z (2005). "Frequency of DRB1-DQB1 two-locus haplotypes in tuberculosis: preliminary report.". Tuberculosis (Edinb) 85 (4): 259-67. PMID 15958261.
  44. ^ Salazar M, Varela A, Ramirez L, Uribe O, Vasquez G, Egea E, Yunis E, Iglesias-Gamarra A. "Association of HLA-DRB1*1602 and DRB1*1001 with in Colombian mestizos as markers of Amerindian ancestry.". Int J Cardiol 75 Suppl 1: S113-6. PMID 10980348.
  45. ^ Tan F, Stivers D, Arnett F, Chakraborty R, Howard R, Reveille J (1999). "HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis).". Tissue Antigens 53 (1): 74-80. PMID 10082433.
  46. ^ Dharakul T, Vejbaesya S, Chaowagul W, Luangtrakool P, Stephens H, Songsivilai S (1998). "HLA-DR and -DQ associations with melioidosis.". Hum Immunol 59 (9): 580-6. PMID 9757914.
  47. ^ a b Wongsurawat T, Nakkuntod J, Charoenwongse P, Snabboon T, Sridama V, Hirankarn N (2006). "The association between HLA class II haplotype with Graves' disease in Thai population.". Tissue Antigens 67 (1): 79-83. PMID 16451208.
  48. ^ Park M, Park Y, Song E, Park H, Kim T, Park D, Park K, Cho B (2005). "Association of HLA-DR and -DQ genes with Graves disease in Koreans.". Hum Immunol 66 (6): 741-7. PMID 15993720.
  49. ^ Cervantes J, Lema C, Valentina Hurtado L, Andrade R, Hurtado Gomez L, Torrico L, Zegarra L, Quiroga G, Asturizaga D, Dulon A, Prada R, Panoso W, Yashiki S, Fujiyoshi T, Sonoda S (2003). "HLA-DRB1*1602 allele is positively associated with HPV cervical infection in Bolivian Andean women.". Hum Immunol 64 (9): 890-5. PMID 12941545.
  50. ^ Tan F, Stivers D, Arnett F, Chakraborty R, Howard R, Reveille J (1999). "HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis).". Tissue Antigens 53 (1): 74-80. PMID 10082433.
  51. ^ Arnett F, Howard R, Tan F, Moulds J, Bias W, Durban E, Cameron H, Paxton G, Hodge T, Weathers P, Reveille J (1996). "Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype.". Arthritis Rheum 39 (8): 1362-70. PMID 8702445.
  52. ^ Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J (1997). "HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.". Am J Respir Crit Care Med 156 (5): 1601-5. PMID 9372682.
  53. ^ Planck A, Katchar K, Eklund A, Gripenbäck S, Grunewald J (2003). "T-lymphocyte activity in HLA-DR17 positive patients with active and clinically recovered sarcoidosis.". Sarcoidosis Vasc Diffuse Lung Dis 20 (2): 110-7. PMID 12870720.
  54. ^ Suastegui R, De La Rosa G, Carranza J, Gonzalez-Astiazaran A, Gorodezky C (2001). "Contribution of the MHC class II antigens to the etiology of infantile spasm in Mexican Mestizos.". Epilepsia 42 (2): 210-5. PMID 11240591.
  55. ^ Piyasirisilp S, Schmeckpeper B, Chandanayingyong D, Hemachudha T, Griffin D (1999). "Association of HLA and T-cell receptor gene polymorphisms with Semple rabies vaccine-induced autoimmune encephalomyelitis.". Ann Neurol 45 (5): 595-600. PMID 10319881.
  56. ^ Diamantopoulos E, Andreadis E, Vassilopoulos C, Vlachonikolis I, Tarassi K, Chatzis N, Giannakopoulos N, Papasteriades C (2001). "Association of specific HLA phenotypes with left ventricular mass and carotid intima-media thickness in hypertensives.". Am J Hypertens 14 (7 Pt 1): 632-6. PMID 11465646.
  57. ^ a b Shawkatova I, Michalkova D, Barak L, Fazekasova H, Kuba D, Buc M (2006). "HLA class II allele frequencies in type 1A diabetes mellitus Slovak patients.". Bratisl Lek Listy 107 (3): 76-9. PMID 16796128.
  58. ^ O'Hanlon T, Carrick D, Targoff I, Arnett F, Reveille J, Carrington M, Gao X, Oddis C, Morel P, Malley J, Malley K, Shamim E, Rider L, Chanock S, Foster C, Bunch T, Blackshear P, Plotz P, Love L, Miller F (2006). "Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.". Medicine (Baltimore) 85 (2): 111-27. PMID 16609350.
  59. ^ Lavard L, Madsen H, Perrild H, Jacobsen B, Svejgaard A (1997). "HLA class II associations in juvenile Graves' disease: indication of a strong protective role of the DRB1*0701,DQA1*0201 haplotype.". Tissue Antigens 50 (6): 639-41. PMID 9458117.
  60. ^ Czaja A, Strettell M, Thomson L, Santrach P, Moore S, Donaldson P, Williams R (1997). "Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis.". Hepatology 25 (2): 317-23. PMID 9021941.
  61. ^ a b Sivakumar K, Semino-Mora C, Dalakas M. "An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families.". Brain 120 ( Pt 4): 653-61. PMID 9153127.
  62. ^ Deja G, Jarosz-Chobot P, Polańska J, Siekiera U, Małecka-Tendera E (2006). "Is the Association Between TNF-alpha-308 A Allele and DMT1 Independent of HLA-DRB1, DQB1 Alleles?". Mediators Inflamm 2006 (4): 19724. PMID 17047287.
  63. ^ Kübler K, Arndt P, Wardelmann E, Krebs D, Kuhn W, van der Ven K (2006). "HLA-class II haplotype associations with ovarian cancer.". Int J Cancer 119 (12): 2980-5. PMID 17016821.
  64. ^ Machens A, Löliger C, Pichlmeier U, Emskötter T, Busch C, Izbicki J (1999). "Correlation of thymic pathology with HLA in myasthenia gravis.". Clin Immunol 91 (3): 296-301. PMID 10370374.
  65. ^ Shamim E, Rider L, Miller F (2000). "Update on the genetics of the idiopathic inflammatory myopathies.". Curr Opin Rheumatol 12 (6): 482-91. PMID 11092196.
  66. ^ Parsons K, Kwok W, Gaur L, Nepom G (2000). "Increased frequency of HLA class II alleles DRB1*0301 and DQB1*0201 in Lambert-Eaton myasthenic syndrome without associated cancer.". Hum Immunol 61 (8): 828-33. PMID 10980394.
  67. ^ Jean S, Quelvennec E, Alizadeh M, Guggenbuhl P, Birebent B, Perdriger A, Grosbois B, Pawlotsky P, Semana G. "DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjögren's syndrome genetic susceptibility.". Clin Exp Rheumatol 16 (6): 725-8. PMID 9844767.
  68. ^ Taylor C, Smith S, Morgan C, Stephenson S, Key T, Srinivasan M, Cunningham E, Watson P (2000). "HLA and Mooren's ulceration.". Br J Ophthalmol 84 (1): 72-5. PMID 10611103.
  69. ^ Weinshenker B, Santrach P, Bissonet A, McDonnell S, Schaid D, Moore S, Rodriguez M (1998). "Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study.". Neurology 51 (3): 742-7. PMID 9748020.
  70. ^ Ratanachaiyavong S, Lloyd L, Darke C, McGregor A (1993). "MHC-extended haplotypes in families of patients with Graves' disease.". Hum Immunol 36 (2): 99-111. PMID 8096501.
  71. ^ Tjernström F, Hellmer G, Nived O, Truedsson L, Sturfelt G (1999). "Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus.". Lupus 8 (2): 103-8. PMID 10192503.
  72. ^ Dieye A, Diallo S, Diatta M, Thiam A, Ndiaye R, Bao O, Sarthou J (1997). "[Identification of HLA-DR alleles for susceptibility to rheumatoid polyarthritis in Senegal]". Dakar Med 42 (2): 111-3. PMID 9827131.
  73. ^ Roudier J (2006). "HLA-DRB1 genes and extraarticular rheumatoid arthritis.". Arthritis Res Ther 8 (1): 103. PMID 16542468.
  74. ^ Winchester R (1981). "Genetic aspects of rheumatoid arthritis.". Springer Semin Immunopathol 4 (2): 89-102. PMID 6459655.
  75. ^ Batchelor J, Welsh K, Tinoco R, Dollery C, Hughes G, Bernstein R, Ryan P, Naish P, Aber G, Bing R, Russell G (1980). "Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility.". Lancet 1 (8178): 1107-9. PMID 6103441.
  76. ^ Shornick J, Jenkins R, Artlett C, Briggs D, Welsh K, Kelly S, Garvey M, Black M (1995). "Class II MHC typing in pemphigoid gestationis.". Clin Exp Dermatol 20 (2): 123-6. PMID 8565245.
  77. ^ Matsuyama M, Hashimoto K, Yamasaki Y, Shirakura R, Higuchi R, Miyajima T, Amemiya H (1981). "HLA-DR antigens in pemphigus among Japanese.". Tissue Antigens 17 (2): 238-9. PMID 7233418.
  78. ^ Sakurami T, Ueno Y, Iwaki Y, Park M, Terasaki P, Saji H (1982). "HLA-DR specificities among Japanese with several autoimmune diseases.". Tissue Antigens 19 (2): 129-33. PMID 6954729.
  79. ^ Kashiwabara H, Shishido H, Tomura S, Tuchida H, Miyajima T (1982). "Strong association between IgA nephropathy and HLA-DR4 antigen.". Kidney Int 22 (4): 377-82. PMID 6217371.
  80. ^ Laroni A, Calabrese M, Perini P, Albergoni M, Ranzato F, Tiberio M, Battistin L, Gallo P (2006). "Multiple sclerosis and autoimmune diseases : Epidemiology and HLA-DR association in North-east Italy.". J Neurol 253 (5): 636-9. PMID 16502215.
  81. ^ Angelini G, Morozzi G, Delfino L, Pera C, Falco M, Marcolongo R, Giannelli S, Ratti G, Ricci S, Fanetti G (1992). "Analysis of HLA DP, DQ, and DR alleles in adult Italian rheumatoid arthritis patients.". Hum Immunol 34 (2): 135-41. PMID 1429034.
  82. ^ Fernandez-Viña M, Ramirez L, Raskin P, Stastny P (1993). "Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans.". Tissue Antigens 41 (2): 57-64. PMID 8475491.
  83. ^ Undlien D, Friede T, Rammensee H, Joner G, Dahl-Jørgensen K, Søvik O, Akselsen H, Knutsen I, Rønningen K, Thorsby E (1997). "HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.". Diabetes 46 (1): 143-9. PMID 8971095.
  84. ^ Gross D, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy Z, Field J, Steere A, Huber B (1998). "Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.". Science 281 (5377): 703-6. PMID 9685265.
  85. ^ Matzner Y, Erlich H, Brautbar C, Sanilevitch A, Landau M, Brenner S, Friedmann A (1995). "Identical HLA class II alleles predispose to drug-triggered and idiopathic pemphigus vulgaris.". Acta Derm Venereol 75 (1): 12-4. PMID 7747528.
  86. ^ Lee E, Lendas K, Chow S, Pirani Y, Gordon D, Dionisio R, Nguyen D, Spizuoco A, Fotino M, Zhang Y, Sinha A. "Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris.". Hum Immunol 67 (1-2): 125-39. PMID 16698434.
  87. ^ Undlien D, Friede T, Rammensee H, Joner G, Dahl-Jørgensen K, Søvik O, Akselsen H, Knutsen I, Rønningen K, Thorsby E (1997). "HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.". Diabetes 46 (1): 143-9. PMID 8971095.
  88. ^ Galeazzi M, Sebastiani G, Tincani A, Piette J, Allegri F, Morozzi G, Bellisai F, Scorza R, Ferrara G, Carcassi C, Font J, Passiu G, Smolen J, Papasteriades C, Houssiau F, Nebro A, Ramon Garrido E, Jedryka-Goral A, Marcolongo R (2000). "HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.". Lupus 9 (1): 47-55. PMID 10715100.
  89. ^ Kaibe M, Takakuwa K, Murakawa H, Ishii K, Tamura M, Tanaka K (2006). "Studies on the human leukocyte antigens in patients with polycystic ovary syndrome in a Japanese population--possible susceptibility of HLA-A11 and -DRB1*0403 to patient population with polycystic ovary syndrome.". Am J Reprod Immunol 55 (4): 301-6. PMID 16533342.
  90. ^ Galeazzi M, Sebastiani G, Tincani A, Piette J, Allegri F, Morozzi G, Bellisai F, Scorza R, Ferrara G, Carcassi C, Font J, Passiu G, Smolen J, Papasteriades C, Houssiau F, Nebro A, Ramon Garrido E, Jedryka-Goral A, Marcolongo R (2000). "HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.". Lupus 9 (1): 47-55. PMID 10715100.
  91. ^ Auger I, Sebbag M, Vincent C, Balandraud N, Guis S, Nogueira L, Svensson B, Cantagrel A, Serre G, Roudier J (2005). "Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.". Arthritis Rheum 52 (11): 3424-32. PMID 16255019.
  92. ^ Angelini G, Morozzi G, Delfino L, Pera C, Falco M, Marcolongo R, Giannelli S, Ratti G, Ricci S, Fanetti G (1992). "Analysis of HLA DP, DQ, and DR alleles in adult Italian rheumatoid arthritis patients.". Hum Immunol 34 (2): 135-41. PMID 1429034.
  93. ^ Vázquez-García M, Aláez C, Olivo A, Debaz H, Pérez-Luque E, Burguete A, Cano S, de la Rosa G, Bautista N, Hernández A, Bandera J, Torres L, Kershenobich D, Alvarez F, Gorodezky C (1998). "MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis.". J Hepatol 28 (6): 985-90. PMID 9672174.
  94. ^ Al-Swailem R, Al-Rayes H, Sobki S, Arfin M, Tariq M (2006). "HLA-DRB1 association in Saudi rheumatoid arthritis patients.". Rheumatol Int 26 (11): 1019-24. PMID 16673133.
  95. ^ Ota M, Seki T, Kiyosawa K, Furuta S, Hino K, Kondo T, Fukushima H, Tsuji K, Inoko H (1992). "A possible association between basic amino acids of position 13 of DRB1 chains and autoimmune hepatitis.". Immunogenetics 36 (1): 49-55. PMID 1350267.
  96. ^ Fernandez-Viña M, Ramirez L, Raskin P, Stastny P (1993). "Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans.". Tissue Antigens 41 (2): 57-64. PMID 8475491.
  97. ^ Undlien D, Friede T, Rammensee H, Joner G, Dahl-Jørgensen K, Søvik O, Akselsen H, Knutsen I, Rønningen K, Thorsby E (1997). "HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.". Diabetes 46 (1): 143-9. PMID 8971095.
  98. ^ Hashimoto K, Maruyama H, Nishiyama M, Asaba K, Ikeda Y, Takao T, Iwasaki Y, Kumon Y, Suehiro T, Tanimoto N, Mizobuchi M, Nakamura T (2005). "Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.". Horm Res 64 (5): 253-60. PMID 16254435.
  99. ^ Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K (2005). "Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis.". J Hepatol 42 (4): 578-84. PMID 15763345.
  100. ^ Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K, Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K (2002). "HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population.". Gastroenterology 122 (5): 1264-9. PMID 11984513.
  101. ^ Park Y, Tait B, Kawasaki E, Rowley M, Mackay I. "Closer association of IA-2 humoral autoreactivity with HLA DR3/4 than DQB1*0201/*0302 in Korean T1D patients.". Ann N Y Acad Sci 1037: 104-9. PMID 15699500.
  102. ^ Hermann R, Turpeinen H, Laine A, Veijola R, Knip M, Simell O, Sipilä I, Akerblom H, Ilonen J (2003). "HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families.". Tissue Antigens 62 (2): 162-9. PMID 12889996.
  103. ^ Ueki A, Isozaki Y, Kusaka M (2005). "Anti-caspase-8 autoantibody response in silicosis patients is associated with HLA-DRB1, DQB1 and DPB1 alleles.". J Occup Health 47 (1): 61-7. PMID 15703453.
  104. ^ Singal D, Green D, Reid B, Gladman D, Buchanan W (1992). "HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA.". Ann Rheum Dis 51 (1): 23-8. PMID 1371662.
  105. ^ Raffoux C, David V, Couderc L, Rabian C, Clauvel J, Seligmann M, Colombani J (1987). "HLA-A, B and DR antigen frequencies in patients with AIDS-related persistent generalized lymphadenopathy (PGL) and thrombocytopenia.". Tissue Antigens 29 (1): 60-2. PMID 3495904.
  106. ^ Pollack M, Safai B, Myskowski P, Gold J, Pandey J, Dupont B (1983). "Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.". Tissue Antigens 21 (1): 1-8. PMID 6601312.
  107. ^ Førre O, Dobloug J, Høyeraal H, Thorsby E (1983). "HLA antigens in juvenile arthritis. Genetic basis for the different subtypes.". Arthritis Rheum 26 (1): 35-8. PMID 6401993.
  108. ^ Suciu-Foca N, Jacobs J, Godfrey M, Woodward K, Khan R, Reed E, Rohowsky C (1980). "HLA-DR5 in juvenile rheumatoid arthritis confined to few joints.". Lancet 2 (8184): 40. PMID 6104257.
  109. ^ Farid N, Sampson L, Moens H, Barnard J (1981). "The association of goitrous autoimmune thyroiditis with HLA-DR5.". Tissue Antigens 17 (3): 265-8. PMID 6947505.
  110. ^ Schleusener H, Schernthaner G, Mayr W, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen K, Wenzel K (1983). "HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.". J Clin Endocrinol Metab 56 (4): 781-5. PMID 6131902.
  111. ^ Safai B, Myskowski P, Dupont B, Pollack M (1983). "Association of HLA-DR5 with mycosis fungoides.". J Invest Dermatol 80 (5): 395-7. PMID 6601679.
  112. ^ Shapiro M, Zamir R, Weiss E, Radnay J, Shenkman L (1987). "The polyglandular deficiency syndrome: a new variant in Persian Jews.". J Endocrinol Invest 10 (1): 1-7. PMID 3496374.
  113. ^ Pereira S, Black C, Welsh K, Ansell B, Jayson M, Maddison P, Rowell N (1987). "Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.". J Rheumatol 14 (4): 760-5. PMID 3499513.
  114. ^ Luderschmidt C, Scholz S, Mehlhaff E, König G, Albert E (1987). "Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.". Arch Dermatol 123 (9): 1188-91. PMID 3498440.
  115. ^ Minev M, Martinova F, Belopitova L. "On the association of the HLA system with epilepsy in children.". Epilepsia 28 (1): 74-6. PMID 3098558.
  116. ^ Orecchia G, Belvedere M, Martinetti M, Capelli E, Rabbiosi G (1987). "Human leukocyte antigen region involvement in the genetic predisposition to alopecia areata.". Dermatologica 175 (1): 10-4. PMID 3497062.
  117. ^ Marsh D, Freidhoff L, Ehrlich-Kautzky E, Bias W, Roebber M (1987). "Immune responsiveness to Ambrosia artemisiifolia (short ragweed) pollen allergen Amb a VI (Ra6) is associated with HLA-DR5 in allergic humans.". Immunogenetics 26 (4-5): 230-6. PMID 3498688.
  118. ^ Vargas-Alarcon G, Granados J, Bekker C, Alcocer-Varela J, Alarcón-Segovia D (1995). "Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients.". Arthritis Rheum 38 (9): 1340-1. PMID 7575732.
  119. ^ Lagaay A, D'Amaro J, Ligthart G, Schreuder G, van Rood J, Hijmans W. "Longevity and heredity in humans. Association with the human leucocyte antigen phenotype.". Ann N Y Acad Sci 621: 78-89. PMID 1859103.
  120. ^ Kalogeromitros D, Makris M, Gregoriou S, Mousatou V, Lyris N, Tarassi K, Papasteriades C. "Grape anaphylaxis: a study of 11 adult onset cases.". Allergy Asthma Proc 26 (1): 53-8. PMID 15813289.
  121. ^ Juhasz F, Kozma L, Stenszky V, Gyory F, Luckas G, Farid N (2005). "Well differentiated thyroid carcinoma is associated with human lymphocyte antigen D-related 11 in Eastern Hungarians: a case of changing circumstances.". Cancer 104 (8): 1603-8. PMID 16121403.
  122. ^ Hu C, Wu C, Lee C, Wu C, Tsai H, Chen P, Hsu P (2006). "HLA-DR11 and HLA-DR2 are negatively associated with autoantibody production in chronic hepatitis C.". Ann Rheum Dis 65 (1): 138-9. PMID 16344504.
  123. ^ a b Tighe M, Hall M, Barbado M, Cardi E, Welsh K, Ciclitira P (1992). "HLA class II alleles associated with celiac disease susceptibility in a southern European population.". Tissue Antigens 40 (2): 90-7. PMID 1357780.
  124. ^ a b Miyagawa S, Shinohara K, Kidoguchi K, Fujita T, Fukumoto T, Hashimoto K, Yoshioka A, Shirai T (1997). "Neonatal lupus erythematosus: studies on HLA class II genes and autoantibody profiles in Japanese mothers.". Autoimmunity 26 (2): 95-101. PMID 9546818.
  125. ^ a b Lara-Marquez M, Yunis J, Layrisse Z, Ortega F, Carvallo-Gil E, Montagnani S, Makhatadze N, Pocino M, Granja C, Yunis E (1999). "Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population.". Clin Exp Allergy 29 (1): 60-71. PMID 10051703.
  126. ^ Madeleine M, Brumback B, Cushing-Haugen K, Schwartz S, Daling J, Smith A, Nelson J, Porter P, Shera K, McDougall J, Galloway D (2002). "Human leukocyte antigen class II and cervical cancer risk: a population-based study.". J Infect Dis 186 (11): 1565-74. PMID 12447731.
  127. ^ a b Ju L, Paolozzi L, Delecoeuillerie G, Bourgeois P, Khodja M, Legoff P, Liote F, Sheffer V, Amor B, Charron D. "A possible linkage of HLA-DRB haplotypes with Tiopronin intolerance in rheumatoid arthritis.". Clin Exp Rheumatol 12 (3): 249-54. PMID 7915222.
  128. ^ Thio C, Carrington M, Marti D, O'Brien S, Vlahov D, Nelson K, Astemborski J, Thomas D (1999). "Class II HLA alleles and hepatitis B virus persistence in African Americans.". J Infect Dis 179 (4): 1004-6. PMID 10068598.
  129. ^ Gao X, Barnardo M, Winsey S, Ahmad T, Cook J, Agudelo J, Zhai N, Powell J, Fuggle S, Wojnarowska F (2005). "The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus.". J Invest Dermatol 125 (5): 895-9. PMID 16297186.
  130. ^ Vargas-Alarcon G, Granados J, Bekker C, Alcocer-Varela J, Alarcón-Segovia D (1995). "Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients.". Arthritis Rheum 38 (9): 1340-1. PMID 7575732.
  131. ^ Fujii T, Nojima T, Yasuoka H, Satoh S, Nakamura K, Kuwana M, Suwa A, Hirakata M, Mimori T (2001). "Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease.". Rheumatology (Oxford) 40 (12): 1398-404. PMID 11752512.
  132. ^ Bidwell J, Soong T, Raymond P, Doherty D, Hui K (1992). "HLA genotyping of colorectal carcinoma in the Chinese population.". Hum Immunol 34 (1): 19-23. PMID 1356954.
  133. ^ a b c d Shinomiya N, Nomura Y, Segawa M (2004). "A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan.". Clin Immunol 110 (2): 154-8. PMID 15003812.
  134. ^ Porto T, Coelho I, Boavida J, Pereira C, Nunes J, Mendonça D, Martins B, Sobrinho L, Leite V (2006). "Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomas.". Clin Endocrinol (Oxf) 64 (2): 179-83. PMID 16430717.
  135. ^ Haas J, Truckenbrodt H, Paul C, Hoza J, Scholz S, Albert E. "Subtypes of HLA-DRB1*03, *08, *11, *12, *13 and *14 in early onset pauciarticular juvenile chronic arthritis (EOPA) with and without iridocyclitis.". Clin Exp Rheumatol 12 Suppl 10: S7-14. PMID 7955632.
  136. ^ Säilä H, Pitkäniemi J, Tuomilehto J, Savolainen A, Alakulppi N, Tuomilehto-Wolf E, Leirisalo-Repo M, Aho K (2004). "HLA and susceptibility to juvenile idiopathic arthritis: a study of affected sibpairs in an isolated Finnish population.". J Rheumatol 31 (11): 2281-5. PMID 15517645.
  137. ^ Underhill J, Donaldson P, Bray G, Doherty D, Portmann B, Williams R (1992). "Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype.". Hepatology 16 (6): 1404-8. PMID 1359995.
  138. ^ a b Charatcharoenwitthaya P, Lindor K. "Current concepts in the pathogenesis of primary biliary cirrhosis.". Ann Hepatol 4 (3): 161-75. PMID 16177655.
  139. ^ White A, Rostom A (1994). "HLA antigens in Arabs with lichen planus.". Clin Exp Dermatol 19 (3): 236-7. PMID 8033385.
  140. ^ Kübler K, Arndt P, Wardelmann E, Krebs D, Kuhn W, van der Ven K (2006). "HLA-class II haplotype associations with ovarian cancer.". Int J Cancer 119 (12): 2980-5. PMID 17016821.
  141. ^ Madeleine M, Brumback B, Cushing-Haugen K, Schwartz S, Daling J, Smith A, Nelson J, Porter P, Shera K, McDougall J, Galloway D (2002). "Human leukocyte antigen class II and cervical cancer risk: a population-based study.". J Infect Dis 186 (11): 1565-74. PMID 12447731.
  142. ^ Pascual M, Nieto A, López-Nevot M, Ramal L, Matarán L, Caballero A, Alonso A, Martín J, Zanelli E (2001). "Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition.". Arthritis Rheum 44 (2): 307-14. PMID 11229460.
  143. ^ Sospedra M, Muraro P, Stefanová I, Zhao Y, Chung K, Li Y, Giulianotti M, Simon R, Mariuzza R, Pinilla C, Martin R (2006). "Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype.". J Immunol 176 (3): 1951-61. PMID 16424227.
  144. ^ Joko S, Numaga J, Kawashima H, Namisato M, Maeda H (2000). "Human leukocyte antigens in forms of leprosy among Japanese patients.". Int J Lepr Other Mycobact Dis 68 (1): 49-56. PMID 10834069.
  145. ^ Smikie M, Pascoe R, Barton E, Morgan O, Christian N, Dowe G, Roye-Green K, Bailey V, James O (2001). "HLA-DRB3*0101 is associated with Graves' disease in Jamaicans.". Clin Endocrinol (Oxf) 55 (6): 805-8. PMID 11895223.
  146. ^ a b Chen Q, Huang W, She J, Baxter F, Volpe R, Maclaren N (1999). "HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective.". J Clin Endocrinol Metab 84 (9): 3182-6. PMID 10487684.
  147. ^ Grunewald J, Berlin M, Olerup O, Eklund A (2000). "Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis.". Am J Respir Crit Care Med 161 (3 Pt 1): 814-8. PMID 10712327.
  148. ^ Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A (2001). "HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis.". Tissue Antigens 57 (1): 87-90. PMID 11169267.
  149. ^ Zabay J, Marco J, Soler J, Contu L, Cappai L, Carcassi C, Gómez G, Mulet J, Munar M, Viader C (2005). "Association of HLA-DRB3*0202 and serum IgG antibodies to Chlamydia pneumoniae with essential hypertension in a highly homogeneous population from Majorca (Balearic Islands, Spain).". J Hum Hypertens 19 (8): 615-22. PMID 15905891.
  150. ^ Oh H, Kwon S, Kim C, Choe B, Ko C, Jung H, Suh J, Lee J (2004). "Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children.". J Korean Med Sci 19 (3): 426-30. PMID 15201511.
  151. ^ Galeazzi M, Sebastiani G, Tincani A, Piette J, Allegri F, Morozzi G, Bellisai F, Scorza R, Ferrara G, Carcassi C, Font J, Passiu G, Smolen J, Papasteriades C, Houssiau F, Nebro A, Ramon Garrido E, Jedryka-Goral A, Marcolongo R (2000). "HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.". Lupus 9 (1): 47-55. PMID 10715100.
  152. ^ Cariappa A, Sands B, Forcione D, Finkelstein D, Podolsky D, Pillai S (1998). "Analysis of MHC class II DP, DQ and DR alleles in Crohn's disease.". Gut 43 (2): 210-5. PMID 10189846.
  153. ^ Terauchi M, Yanagawa T, Ishikawa N, Ito K, Fukazawa T, Maruyama H, Saruta T (2003). "Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto's thyroiditis in Japanese population.". J Endocrinol Invest 26 (12): 1208-12. PMID 15055474.
  154. ^ Zamani M, Spaepen M, Sghar S, Huang C, Westerhof W, Nieuweboer-Krobotova L, Cassiman J (2001). "Linkage and association of HLA class II genes with vitiligo in a Dutch population.". Br J Dermatol 145 (1): 90-4. PMID 11453913.
  155. ^ Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y (1995). "HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.". J Exp Med 181 (5): 1835-45. PMID 7536796.
  156. ^ Corzo D, Yunis J, Salazar M, Lieberman J, Howard A, Awdeh Z, Alper C, Yunis E (1995). "The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups.". Blood 86 (10): 3835-40. PMID 7579351.
  157. ^ Kobayashi H, Kokubo T, Takahashi M, Sato K, Miyokawa N, Kimura S, Kinouchi R, Katagiri M (1998). "Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient.". Immunogenetics 47 (5): 398-403. PMID 9510558.
  158. ^ a b Robinson J, Waller M, Parham P, de Groot N, Bontrop R, Kennedy L, Stoehr P, Marsh S (2003). "IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex.". Nucleic Acids Res 31 (1): 311-4. PMID 12520010.
Retrieved from "http://en.wikipedia.org../../../h/l/a/HLA-DR_8cb2.html"